EmpoweringIn-andOut-LicensingThroughAI-DrivenDecisionMaking
Expand Reach, Discover New Indications for Out-Licensing
Unlock New Potential with AI
AI uncovers new therapeutic indications for existing assets, expand life cycle management opportunities to increase their value, and broaden the pool of potential licensees by opening new areas of interest
Comprehensive Partner - Ready Materials
We prepare complete pitch decks, evidence lists, and matching company databases for each indication, clearly showcasing the scientific rationale and commercial potential. Partners receive all the materials they need for informed and fast decision-making
Precision Partner Matching
We combine AI with expert curation to identify companies best aligned with each indication, target potential licensees interested in newly identified opportunities, and continuously refine matches to ensure relevance and high-quality engagement
Deal Execution
We work closely with partners to engage qualified licensees, negotiate term sheets, and, when needed, finalize definitive agreements. Our proven track record spans multiple Big Pharma and Biotech deals, driving repeat partnerships and scalable results
100x More Assets, 100x Faster Assessments for In-Licensing
Define & Expand the Search Space
Beyond traditional sources like conferences or databases, searching the entire web to find every available compound that fits your criteria—whether by indication, development stage, or other parameters. Our AI then uncovers new potential uses for existing drugs, expanding your opportunities even further
Comprehensive AI-Driven Analysis
Powered by H100 GPUs—ranking among the top 3 in AI for life sciences globally—our platform conducts thorough analyses across - Scientific rationale, IP landscape, Clinical development pathways, Commercial potential, among others. This parallel analyses, we make sure no promising opportunity is ever missed
High-Throughput Asset Prioritization
Our AI screens hundreds of assets at once, identifying high-value candidates that can often be confirmed with just a single lab experiment—dramatically speeding up the discovery-to-decision process
Virtual Due Diligence & Transactability Assessment
Each shortlisted asset undergoes a rigorous virtual assessment, delivering clear, data-backed insights into its licensing or acquisition potential—so you know exactly what's ready to move forward
Interactive & Iterative Delivery
Get new matching assets every two weeks customized to your feedback and goals. Our pace adapts to your decisions, creating a truly interactive and responsive discovery process
Expand Reach, Discover New Indications for Out-Licensing
Unlock New Potential with AI
AI uncovers new therapeutic indications for existing assets, expand life cycle management opportunities to increase their value, and broaden the pool of potential licensees by opening new areas of interest
Comprehensive Partner - Ready Materials
We prepare complete pitch decks, evidence lists, and matching company databases for each indication, clearly showcasing the scientific rationale and commercial potential. Partners receive all the materials they need for informed and fast decision-making
Precision Partner Matching
We combine AI with expert curation to identify companies best aligned with each indication, target potential licensees interested in newly identified opportunities, and continuously refine matches to ensure relevance and high-quality engagement
Deal Execution
We work closely with partners to engage qualified licensees, negotiate term sheets, and, when needed, finalize definitive agreements. Our proven track record spans multiple Big Pharma and Biotech deals, driving repeat partnerships and scalable results
100x More Assets, 100x Faster Assessments for In-Licensing
Define & Expand the Search Space
Beyond traditional sources like conferences or databases, searching the entire web to find every available compound that fits your criteria—whether by indication, development stage, or other parameters. Our AI then uncovers new potential uses for existing drugs, expanding your opportunities even further
Comprehensive AI-Driven Analysis
Powered by H100 GPUs—ranking among the top 3 in AI for life sciences globally—our platform conducts thorough analyses across - Scientific rationale, IP landscape, Clinical development pathways, Commercial potential, among others. This parallel analyses, we make sure no promising opportunity is ever missed
High-Throughput Asset Prioritization
Our AI screens hundreds of assets at once, identifying high-value candidates that can often be confirmed with just a single lab experiment—dramatically speeding up the discovery-to-decision process
Virtual Due Diligence & Transactability Assessment
Each shortlisted asset undergoes a rigorous virtual assessment, delivering clear, data-backed insights into its licensing or acquisition potential—so you know exactly what's ready to move forward
Interactive & Iterative Delivery
Get new matching assets every two weeks customized to your feedback and goals. Our pace adapts to your decisions, creating a truly interactive and responsive discovery process
Introducing Asset Exchange
A smarter way to find your next high-value licensing opportunity
Try Asset Exchange Now
We don't just discover drugs,
we manage their future
Talk to us to explore licensing, partnerships, or how AI can reshape your drug pipeline
Contact Us
